Curaleaf enters European cannabis market with $286 million acquisition of Emmac Life Sciences

MJBizDaily
By John SchroyerMar 9, 2021, 6:47 pm220 pts
Curaleaf Holdings said Tuesday it signed a $286 million definitive agreement to acquire London-based medical marijuana company Emmac Life Sciences, giving the Massachusetts-based multistate operator a major foothold in the European cannabis market and a leg up on rival businesses. The terms of the deal call for…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Happy 4th of July! 69

Trump’s VA Secretary Is ‘Particularly Proud’ Of Psychedelic Research Aimed At Helping Veterans With PTSD 68

Marijuana Use Is Tied To ‘Significantly Higher Sexual Desire And Arousal,’ New Study Shows 63

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.